South Africa
Healthcare Oncology
Submit newsAdvertiseSubscribe
NewsPress Office NewsCompaniesJobsEventsPeopleMultimediaFeaturesOpinion
AdvertiseSubmit news

Industries

All industriesAgricultureAutomotiveConstruction & EngineeringEducationEnergy & MiningEntrepreneurshipESG & SustainabilityFinanceHealthcareHR & ManagementICTLegalLifestyleLogistics & TransportManufacturingMarketing & MediaPropertyRetailTourism & Travel

Features

Loeries Creative WeekPendoringEffie AwardsBizTrendsBizTrendsTVIMC ConferenceOrchids and OnionsThe Lead CreativeMore Sections..

In the news

Skin RenewalStoneMultiChoiceMedihelpIcon OncologyEnquire about a company Biz Press Office
Agriculture
Automotive
Construction & Engineering
Education
Energy & Mining
Entrepreneurship
ESG & Sustainability
Finance
Healthcare
HR & Management
ICT
Legal
Lifestyle
Logistics & Transport
Manufacturing
Marketing & Media
Property
Retail
Tourism & Travel

News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

Submit content

My Account

Advertise with us

Trending

2 days 7 days 30 days By Industry

Subscribe & Follow

Advertise your job vacancies
    Post your Job Ad here >>
    Search jobs

    Can the degree of tumour angiogenesis can assessed in vivo?

    Differentiation of angiogenic burden in human cancer xenografts using a perfusion type optical contrast agent (SIDAG).
    14 Mar 2008
    14 Mar 2008

    With the rapid evolvement of fluorescence imaging in oncology, non-targeted fluorochromes are currently under investigation for clinical use. Here we investigated if the degree of tumour angiogenesis can be assessed in vivo by planar and tomographic methods using a perfusion-type cyanine dye (SIDAG).

    Read the full document

    Share this article
    NextOptions
    TopicsNext
    Top stories
    More news
    Let's do Biz